CPC A61L 27/3817 (2013.01) [A61F 2/30756 (2013.01); A61F 2/441 (2013.01); A61K 35/32 (2013.01); A61K 35/33 (2013.01); A61K 38/18 (2013.01); A61K 45/06 (2013.01); A61L 27/3852 (2013.01); A61L 27/3895 (2013.01); C12N 5/0655 (2013.01); A61F 2/3099 (2013.01); A61F 2/32 (2013.01); A61F 2/38 (2013.01); A61F 2/3804 (2013.01); A61F 2/40 (2013.01); A61F 2002/286 (2013.01); A61F 2002/2817 (2013.01); A61F 2002/30062 (2013.01); A61F 2002/30586 (2013.01); A61F 2002/30677 (2013.01); A61F 2002/30762 (2013.01); A61F 2002/30764 (2013.01); A61F 2002/30766 (2013.01); A61F 2002/444 (2013.01); A61F 2002/445 (2013.01); A61F 2002/4445 (2013.01); A61F 2002/4635 (2013.01); A61F 2210/0004 (2013.01); A61L 2430/06 (2013.01); C12N 2500/02 (2013.01); C12N 2500/38 (2013.01); C12N 2501/155 (2013.01); C12N 2506/1307 (2013.01); C12N 2521/00 (2013.01); C12N 2533/74 (2013.01)] | 5 Claims |
1. A composition comprising chondrocyte-like cells derived from fibroblasts, wherein said chondrocyte-like cells produce Sox-9 protein and one or more of aggrecan, type II collagen, cartilage link protein, perlecan, and sulfated proteoglycan.
|